When they first came to market for diabetes, they noticed a side effect was weight loss. A potentially complex treatment option The patient side of the equation can be complex, as some experts believe these medications, whether for diabetes or weight loss, may need to be taken throughout a persons life, as a direct treatment or maintenance therapy
2 Concurrently, the Food and Drug Administration (FDA) threatened to restrict access to the bulk ingredients required for compounding these medications, noting that GLP-1 drugs were no longer in a shortage
Once you have reached your target weight, you do not need to stay at the dose that got you there
thanks Can you please tell me more about how
Liraglutide, a once daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)